Oragenics Inc. (OGEN) Financials

OGEN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 7.9 million 1.4 million
2023-06-30 8.5 million 1.2 million
2023-03-31 14.8 million 1.7 million
2022-12-31 14.8 million 1.7 million

OGEN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.5 million 402925
2023-06-30 -2.6 million 63628
2023-03-31 -2.4 million -95577
2022-12-31 -2.4 million -95577

OGEN Net Income

No data available :(

OGEN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.8 million - 24337
2023-06-30 6.5 million - 255994
2023-03-31 11.4 million - 306650
2022-12-31 - - 356886

OGEN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.4 million
2023-06-30 2.0 million
2023-03-31 2.0 million
2022-12-31 2.0 million

OGEN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 769350 1.3 million -
2023-06-30 - 2.0 million 1.1 million -
2023-03-31 3438 523158 883573 -
2022-12-31 3438 523158 883573 -

OGEN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 7466 4785
2023-06-30 13163 11303
2023-03-31 131521 13073
2022-12-31 131521 -

OGEN

Price: $1.07

52 week price:
1.01
7.74

Earnings Per Share: -9.18 USD

P/E Ratio: -0.80

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 23200

Market Capitalization: 5.7 million

Links: